<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03160560</url>
  </required_header>
  <id_info>
    <org_study_id>LLUSD-RPR-Malodor-ADA-2016</org_study_id>
    <nct_id>NCT03160560</nct_id>
  </id_info>
  <brief_title>Controlling Oral Malodor by ClōSYS® Oral Rinse</brief_title>
  <official_title>Efficacy of ClōSYS® Oral Rinse Products in Human Subjects in Controlling Oral Malodor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rowpar Pharmaceuticals, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Loma Linda University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rowpar Pharmaceuticals, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this Study is to assess the efficacy of two ClōSYS Oral Rinse products in&#xD;
      human subjects in controlling oral malodor in partial fulfillment of the requirements for&#xD;
      American Dental Association's (ADA) requirement for obtaining ADA Seal for malodor.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study Design:&#xD;
&#xD;
      The products used in the study are: ClōSYS Alcohol-Free Oral Rinse (also referred as ClōSYS&#xD;
      Unflavored Oral Rinse) and ClōSYS justRIGHT MILD MINT Oral Rinse (also referred as ClōSYS&#xD;
      Flavored Oral Rinse or Gentle Mint Flavored Oral Rinse). This is an in-vivo, eight-week, a&#xD;
      single-center, randomized, double-blind (subject/investigator), 2-way cross-over design&#xD;
      clinical study. There are two independent groups. Each subject of each group gets crossed&#xD;
      over to the other sub-group within a same group after the washout period. Each group has&#xD;
      their own control group. In the first phase, 25 subjects (50%) of each group are randomly&#xD;
      assigned to the active group; the other 25 subjects are assigned to the control group. In the&#xD;
      second phase, the participants will be crossed over within sub-group assignment. The Study&#xD;
      enrolled 100 subjects, aged 21 to 65 years, with a slight to strong intrinsic oral malodor,&#xD;
      as determined by a panel of trained odor judges calibrated and standardized using a range of&#xD;
      standard odorants sufficient to reflect the different patterns of nose receptors.&#xD;
&#xD;
      Study Plan:&#xD;
&#xD;
      Subjects will receive verbal and written oral hygiene instructions, and either one bottle (16&#xD;
      oz. each) of ClōSYS Unflavored Oral Rinse, ClōSYS Flavored Oral Rinse- or Placebo Oral Rinse&#xD;
      each week. Subjects will also receive measuring cups for dispensing the rinse and a diary log&#xD;
      for recording usage (the Oral Hygiene Kit) for use during the treatment. After a 2-week wash&#xD;
      out period, each subject will receive another bottle of oral rinse according to their group&#xD;
      assignment.&#xD;
&#xD;
      Subjects will be instructed to rinse twice a day, each in the morning and in the evening,&#xD;
      with 15 mL mouth rinse for 30 seconds. They will note in their patient's log the date and&#xD;
      time of rinsing.&#xD;
&#xD;
      Subjects will be instructed to continue with their normal oral hygiene practices, including&#xD;
      tooth brushing but omitting any use of oral rinses or mouthwashes except for the Study&#xD;
      materials. The subjects also will be instructed not to use other non-study related products&#xD;
      such as breath mints, lozenge, gums, etc. as well as refraining from elective dental&#xD;
      procedures during the study period.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Actual">November 2016</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Malodor as Measured by Organoleptic Score</measure>
    <time_frame>At baseline and weekly for 3 weeks for each condition and cross-over</time_frame>
    <description>A 6-level organoleptic score from 0 - 5 will be used. Score of 0 indicating malodor cannot be detected and score of 5 indicating very strong malodor. Breath scores were compared to baseline with malodor intensity reduction recorded as negative.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Oral Malodor</condition>
  <arm_group>
    <arm_group_label>Test-Unflavored Rinse</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CloSYS Oral Rinse product containing 0.1% stabilized chlorine dioxide (sodium chlorite) in aqueous solution.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test-Flavored Rinse</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CloSYS Oral Rinse product containing 0.1% stabilized chlorine dioxide (sodium chlorite) in aqueous solution with mint flavoring.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>CloSYS Oral Rinse product (no chlorine dioxide)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ClōSYS® Unflavored Rinse</intervention_name>
    <description>Subjects in Test group will receive ClōSYS® Unflavored Rinse.</description>
    <arm_group_label>Test-Unflavored Rinse</arm_group_label>
    <other_name>Mouth rinse</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ClōSYS® Flavored Rinse</intervention_name>
    <description>Subjects in Test group will receive ClōSYS® Flavored Rinse.</description>
    <arm_group_label>Test-Flavored Rinse</arm_group_label>
    <other_name>Mouth rinse</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Subjects in Placebo group will receive Placebo Rinse.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Completion of the Informed Consent.&#xD;
&#xD;
          -  Must be able to follow verbal/written instructions.&#xD;
&#xD;
          -  Between 21 to 65 years of age, male or female.&#xD;
&#xD;
          -  Has normal oral interior cheek wall tissues.&#xD;
&#xD;
          -  In good general health.&#xD;
&#xD;
          -  Should not have any severe or debilitating disease that may impede participation.&#xD;
&#xD;
          -  Average organoleptic intensity rating of at &gt;2.6 but &lt;4.5 on an intensity scale of&#xD;
             0-5.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant or nursing.&#xD;
&#xD;
          -  Diagnosis of Xerostomia, including medication induced Xerostomia.&#xD;
&#xD;
          -  Oral or extraoral piercing that interferes with the clinical assessments in the mouth.&#xD;
&#xD;
          -  Fixed or removable oral appliance.&#xD;
&#xD;
          -  Advanced periodontal disease or excessive gingival recession.&#xD;
&#xD;
          -  Known allergy or sensitivity to study products.&#xD;
&#xD;
          -  Unwilling to abstain from all oral hygiene products other than those prescribed for&#xD;
             the study.&#xD;
&#xD;
          -  Heavy deposits of calculus, either supragingival and/or subgingival.&#xD;
&#xD;
          -  History of severe transmittable infectious disease e.g. hepatitis, HIV, tuberculosis.&#xD;
&#xD;
          -  Medical or dental condition that would be unduly affected by participation in this&#xD;
             study.&#xD;
&#xD;
          -  Any other condition that may interfere with the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yiming Li, DDS MSD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Center for Dental Research, Loma Linda University School of Dentistry</affiliation>
  </overall_official>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>May 10, 2017</study_first_submitted>
  <study_first_submitted_qc>May 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 19, 2017</study_first_posted>
  <results_first_submitted>August 31, 2020</results_first_submitted>
  <results_first_submitted_qc>December 13, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">January 7, 2021</results_first_posted>
  <last_update_submitted>December 13, 2020</last_update_submitted>
  <last_update_submitted_qc>December 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Results are available upon request</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>unlimited</ipd_time_frame>
    <ipd_access_criteria>Request</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 1, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/60/NCT03160560/SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Study panelists were recruited by placing IRB-approved advertisements in the the Loma Linda University newsletter and local communities. Potential subjects were interviewed by telephone and screened for their eligibility to participate in the study.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Test-Unflavored Rinse, Then Placebo</title>
          <description>Participants received ClōSYS® Unflavored Rinse for use for 3 weeks. After a 2-week washout period, the subjects received Placebo rinse for use for 3 weeks.</description>
        </group>
        <group group_id="P2">
          <title>Test-Flavored Rinse, Then Placebo</title>
          <description>Participants received ClōSYS® Flavored Rinse for use for 3 weeks. After a 2-week washout period, the subjects received Placebo rinse for use for 3 weeks.</description>
        </group>
        <group group_id="P3">
          <title>Placebo, Then Flavored Rinse</title>
          <description>Participants received Placebo for use for 3 weeks. After a 2-week washout period, the subjects received ClōSYS® Flavored Rinse rinse for use for 3 weeks.</description>
        </group>
        <group group_id="P4">
          <title>Placebo, Then Unflavored Rinse</title>
          <description>Participants received Placebo for use for 3 weeks. After a 2-week washout period, the subjects received ClōSYS® Unflavored Rinse rinse for use for 3 weeks.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Intervention (3 Weeks)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="25"/>
                <participants group_id="P3" count="25"/>
                <participants group_id="P4" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="24"/>
                <participants group_id="P3" count="24"/>
                <participants group_id="P4" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Washout (2 Weeks)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="24"/>
                <participants group_id="P3" count="24"/>
                <participants group_id="P4" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="24"/>
                <participants group_id="P3" count="24"/>
                <participants group_id="P4" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Second Intervention (3 Weeks)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="24"/>
                <participants group_id="P3" count="24"/>
                <participants group_id="P4" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="24"/>
                <participants group_id="P3" count="24"/>
                <participants group_id="P4" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Test-Unflavored Rinse, Then Placebo</title>
          <description>Participants received ClōSYS® Unflavored Rinse, Then Placebo Unflavored Rinse</description>
        </group>
        <group group_id="B2">
          <title>Test-Flavored Rinse, Then Placebo</title>
          <description>Subjects received ClōSYS® Flavored Rinse, Then Placebo Flavored Rinse.</description>
        </group>
        <group group_id="B3">
          <title>Placebo, Then Flavored Rinse</title>
          <description>Subjects in Placebo group received Placebo Rinse, then ClōSYS® Flavored Rinse</description>
        </group>
        <group group_id="B4">
          <title>Placebo, Then Unflavored Rinse</title>
          <description>Subjects in Placebo group received Placebo Rinse, then ClōSYS® Unflavored Rinse.</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="25"/>
            <count group_id="B2" value="25"/>
            <count group_id="B3" value="25"/>
            <count group_id="B4" value="25"/>
            <count group_id="B5" value="100"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="25"/>
                    <count group_id="B4" value="25"/>
                    <count group_id="B5" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="25"/>
                    <measurement group_id="B4" value="25"/>
                    <measurement group_id="B5" value="100"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <population>Participant-level, continuous data were collected for participants who did not discontinue the study.</population>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                    <count group_id="B2" value="24"/>
                    <count group_id="B3" value="24"/>
                    <count group_id="B4" value="25"/>
                    <count group_id="B5" value="96"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45.6" spread="13.5"/>
                    <measurement group_id="B2" value="40.6" spread="13.3"/>
                    <measurement group_id="B3" value="38.2" spread="13.3"/>
                    <measurement group_id="B4" value="45.7" spread="13.9"/>
                    <measurement group_id="B5" value="42.5" spread="13.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>Sex data were only collected from participants that did not elect to discontinue the study.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                    <count group_id="B2" value="24"/>
                    <count group_id="B3" value="24"/>
                    <count group_id="B4" value="25"/>
                    <count group_id="B5" value="96"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="8"/>
                    <measurement group_id="B5" value="52"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="17"/>
                    <measurement group_id="B5" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                    <count group_id="B5" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="25"/>
                    <count group_id="B4" value="25"/>
                    <count group_id="B5" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="25"/>
                    <measurement group_id="B4" value="25"/>
                    <measurement group_id="B5" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Malodor as Measured by Organoleptic Score</title>
        <description>A 6-level organoleptic score from 0 - 5 will be used. Score of 0 indicating malodor cannot be detected and score of 5 indicating very strong malodor. Breath scores were compared to baseline with malodor intensity reduction recorded as negative.</description>
        <time_frame>At baseline and weekly for 3 weeks for each condition and cross-over</time_frame>
        <population>All participants</population>
        <group_list>
          <group group_id="O1">
            <title>Unflavored Rinse, Then Placebo</title>
            <description>CloSYS Oral Rinse product containing 0.1% stabilized chlorine dioxide (sodium chlorite) in aqueous solution.&#xD;
ClōSYS® Unflavored Rinse: Subjects in Test group will receive ClōSYS® Unflavored Rinse, then Placebo.</description>
          </group>
          <group group_id="O2">
            <title>Flavored Rinse, Then Placebo</title>
            <description>CloSYS Oral Rinse product containing 0.1% stabilized chlorine dioxide (sodium chlorite) in aqueous solution with mint flavoring.&#xD;
ClōSYS® Flavored Rinse: Subjects in Test group will receive ClōSYS® Flavored Rinse, then Placebo</description>
          </group>
          <group group_id="O3">
            <title>Placebo Flavored, Then Flavored Rinse</title>
            <description>CloSYS Oral Rinse product (no chlorine dioxide)&#xD;
Placebo: Subjects in Placebo group will receive Placebo Rinse, then Flavored CloSYS Oral Rinse.</description>
          </group>
          <group group_id="O4">
            <title>Placebo Unflavored, Then Unflavored Rinse</title>
            <description>CloSYS Oral Rinse product containing 0.1% stabilized chlorine dioxide (sodium chlorite) in aqueous solution.&#xD;
ClōSYS® Unflavored Rinse: Subjects in Test group will receive Placebo, then ClōSYS® Unflavored Rinse.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Malodor as Measured by Organoleptic Score</title>
          <description>A 6-level organoleptic score from 0 - 5 will be used. Score of 0 indicating malodor cannot be detected and score of 5 indicating very strong malodor. Breath scores were compared to baseline with malodor intensity reduction recorded as negative.</description>
          <population>All participants</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="24"/>
                <count group_id="O4" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="25"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.09" spread=".34"/>
                    <measurement group_id="O2" value="3.08" spread=".38"/>
                    <measurement group_id="O3" value="3.03" spread=".19"/>
                    <measurement group_id="O4" value="3.23" spread=".41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="25"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.90" spread=".52"/>
                    <measurement group_id="O2" value="2.92" spread=".31"/>
                    <measurement group_id="O3" value="3.11" spread=".46"/>
                    <measurement group_id="O4" value="3.19" spread=".50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="25"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.64" spread=".48"/>
                    <measurement group_id="O2" value="2.78" spread=".40"/>
                    <measurement group_id="O3" value="3.07" spread=".53"/>
                    <measurement group_id="O4" value="3.12" spread=".43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="25"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.58" spread=".43"/>
                    <measurement group_id="O2" value="2.68" spread=".51"/>
                    <measurement group_id="O3" value="3.07" spread=".44"/>
                    <measurement group_id="O4" value="3.19" spread=".43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline 2-Crossover</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="25"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.44" spread=".50"/>
                    <measurement group_id="O2" value="3.20" spread=".44"/>
                    <measurement group_id="O3" value="3.15" spread=".42"/>
                    <measurement group_id="O4" value="3.14" spread=".46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="25"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.18" spread=".61"/>
                    <measurement group_id="O2" value="3.04" spread=".49"/>
                    <measurement group_id="O3" value="3.17" spread=".46"/>
                    <measurement group_id="O4" value="3.0" spread=".41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 7</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="25"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.01" spread=".59"/>
                    <measurement group_id="O2" value="2.94" spread=".48"/>
                    <measurement group_id="O3" value="3.13" spread=".40"/>
                    <measurement group_id="O4" value="3.10" spread=".5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="25"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.96" spread=".49"/>
                    <measurement group_id="O2" value="2.83" spread=".44"/>
                    <measurement group_id="O3" value="3.10" spread=".40"/>
                    <measurement group_id="O4" value="3.09" spread=".43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Baseline, Week 1, Week 2, Week 3</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.010</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Baseline, Week 1, Week 2, Week 3</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.932</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Baseline 2, Week 6, Week 7, Week 8</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.853</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Baseline-2, Week 6, Week 7, Week 8</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.032</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Baseline, Week 1, Week 2, Week 3</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Baseline, Week 1, Week 2, Week 3</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.750</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Baseline 2, Week 6, Week 7, Week 8</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.810</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Baseline 2, Week 6, Week 7, Week 8</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.006</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Eight weeks (the entire course of the study)</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Test-Unflavored Rinse</title>
          <description>ClōSYS® Unflavored Rinse: Subjects in Test group will receive ClōSYS® Unflavored Rinse</description>
        </group>
        <group group_id="E2">
          <title>Test-Flavored Rinse</title>
          <description>ClōSYS® Flavored Rinse: Subjects in Test group will receive ClōSYS® Flavored Rinse</description>
        </group>
        <group group_id="E3">
          <title>Placebo Flavored Rinse</title>
          <description>Placebo: Subjects in Placebo group will receive Placebo Rinse.</description>
        </group>
        <group group_id="E4">
          <title>Placebo Unflavored Rinse</title>
          <description>Placebo: Subjects in Placebo group will receive Placebo Rinse</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Yiming Li, DDS, MSD, PhD, Professor and Associate Dean for Research</name_or_title>
      <organization>Center for Dental Research, Loma Linda University</organization>
      <phone>909-558-8069</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

